What is Global Continuous Glucose Monitoring Devices Market?
The Global Continuous Glucose Monitoring Devices Market is a rapidly expanding sector in the healthcare industry. These devices are designed to provide real-time measurements of a person's blood glucose levels, allowing for more accurate and timely management of conditions such as diabetes. The market is driven by the increasing prevalence of diabetes worldwide, advancements in technology, and the growing demand for minimally invasive procedures. In 2023, the market was valued at a substantial US$ 4612 million and is projected to reach an impressive US$ 5979.4 million by 2030. This growth is expected to occur at a compound annual growth rate (CAGR) of 3.7% during the forecast period from 2024 to 2030.
Sensors, Transmitters & Receivers, Insulin Pumps in the Global Continuous Glucose Monitoring Devices Market:
The Global Continuous Glucose Monitoring Devices Market is segmented into sensors, transmitters & receivers, and insulin pumps. Sensors are the primary component of these devices, responsible for detecting changes in glucose levels. Transmitters & receivers then process this information and relay it to the user or their healthcare provider. Insulin pumps, on the other hand, are devices that deliver insulin to the body based on the information received from the sensors. These components work together to provide a comprehensive solution for managing blood glucose levels, contributing significantly to the market's growth.
Diabetic Patients, Healthy Individuals in the Global Continuous Glucose Monitoring Devices Market:
The usage of Global Continuous Glucose Monitoring Devices is not limited to diabetic patients. While they are the primary users, healthy individuals are also starting to use these devices as a preventive measure. For diabetic patients, these devices are a lifeline, helping them monitor their glucose levels continuously and manage their condition effectively. For healthy individuals, these devices provide a way to monitor their glucose levels and take preventive measures if any irregularities are detected. This dual usage is a significant factor contributing to the market's growth.
Global Continuous Glucose Monitoring Devices Market Outlook:
Looking at the market outlook, the Global Continuous Glucose Monitoring Devices Market is showing promising growth. In 2023, the market was valued at US$ 4612 million. With a steady growth rate of 3.7% CAGR, it is expected to reach US$ 5979.4 million by 2030. This growth is driven by the increasing prevalence of diabetes and the growing demand for minimally invasive procedures. The market is dominated by the top three manufacturers, who hold about 95% of the market share. This dominance is a testament to the quality and reliability of their products.
| Report Metric | Details |
| Report Name | Continuous Glucose Monitoring Devices Market |
| Accounted market size in 2023 | US$ 4612 million |
| Forecasted market size in 2030 | US$ 5979.4 million |
| CAGR | 3.7% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Abbott Laboratories, Echo Therapeutics, Inc., Dexcom, Inc., GlySens Incorporated, Medtronic plc, Senseonics Holdings, Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AgaMatrix, Inc., Glucovation, GlySure, Arkray USA, Inc., OrSense |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
